The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ELVN FINANCIAL STATEMENTS

Enliven Therapeutics Inc. — balance sheet, income statement and cash flow trends

ELVNEnliven Therapeutics Inc.

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M-50 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-60 K $ · -Infinity%Operating Income-124.4 M $ · -Infinity%Pre-tax Income-105.9 M $ · -Infinity%Net Income to Owners-105.9 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-60 K $—
Operating Income-124.4 M $—
EBITDA-105.8 M $—
Net Income to Owners-105.9 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets910.2 M
  • Equity895.1 M $98%
  • Current Liabilities14.2 M $2%
  • Long-term Liabilities913 K $0%

Key Figures

YoY change
Total Assets910.2 M $+80.6%
Total Liabilities15.1 M $-2.2%
Total Equity895.1 M $+83.3%
Cash & ST Investments895.2 M $+82.5%
Total Debt1.5 M $+160.3%
Net Debt-134 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-75 M-50 M-25 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0-66.9 M $Operating-390.7 M $Investing473.7 M $Financing16.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-66.9 M $—
Capital Expenditures100 K $-44.8%
Free Cash Flow-67 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ELVN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.